AI assistant
Vistin Pharma — Earnings Release 2019
Aug 29, 2019
3782_rns_2019-08-29_29fea67f-ed41-4620-bb02-db8cf1a1884b.html
Earnings Release
Open in viewerOpens in your device viewer
Vistin Pharma ASA: Second quarter 2019 financial results
Vistin Pharma ASA: Second quarter 2019 financial results
Oslo, Norway, 29 August 2019
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial
results for the second quarter of 2019, with an increase in revenue of 11%.
The revenues for the second quarter 2019 ended at NOK 60.8 million (Q2 2018: NOK
54.6 million).
The net profit ended at NOK 0.4 million (-12.3) in the second quarter 2019,
which included an unrealised financial loss on oil derivatives of NOK 10.2
million for the period.
Vistin Pharma had cash of NOK 290.7 million as of 30 June 2019.
The second quarter conference call, which will be held today, 29 August, at 8am
(CEST), will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:........ 9184908
International Dial-In: ..... +44 (0) 2071 928000
Norway, Oslo................. 23960264
United States, New York. 16315107495
Webcast:
https://edge.media-server.com/m6/p/cvjpg4fj
The conference call will be held in Norwegian.
Please find the report for the second quarter 2019 enclosed. The report will
also be made available on www.vistin.com (http://www.vistin.com).
*****
For further information, please contact:
Kjell-Erik Nordby
CEO
+47 91 36 42 80
Gunnar Manum
CFO
+47 95 17 91 90
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.